Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2012; 18(7): 698-703
Published online Feb 21, 2012. doi: 10.3748/wjg.v18.i7.698
Published online Feb 21, 2012. doi: 10.3748/wjg.v18.i7.698
Figure 3 Median overall survival of all patients starting from the first prescription of 600 mg/d imatinib.
Median OS was 81 wk (95% CI: 36.2-125.8). OS: Overall survival; CI: Confidence interval.
- Citation: Li J, Gong JF, Li J, Gao J, Sun NP, Shen L. Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients. World J Gastroenterol 2012; 18(7): 698-703
- URL: https://www.wjgnet.com/1007-9327/full/v18/i7/698.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i7.698